Bromophenazine derivatives with potent inhibition, dispersion and eradication activities against Staphylococcus aureusbiofilms

Bacterial biofilms are surface-attached communities of bacteria that are: (1) highly prevalent in human infections, and (2) resistant to conventional antibiotic treatments and host immune responses. It has only been in the last similar to 20 years that bacterial biofilms have been identified as a cr...

Full description

Saved in:
Bibliographic Details
Published in:RSC advances 2014-12, Vol.5 (2), p.1120-1124
Main Authors: Garrison, Aaron T, Bai, Fang, Abouelhassan, Yasmeen, Paciaroni, Nicholas G, Jin, Shouguang, Huigens, Robert W
Format: Article
Language:English
Subjects:
Antiinfectives and antibacterials
Bacteria
Biofilms
Derivatives
Dispersions
Human
Inhibitors
Staphylococcus
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Bacterial biofilms are surface-attached communities of bacteria that are: (1) highly prevalent in human infections, and (2) resistant to conventional antibiotic treatments and host immune responses. It has only been in the last similar to 20 years that bacterial biofilms have been identified as a critical biomedical hurdle in infectious disease and human health. Staphylococcus aureusis a leading cause of nosocomial and community-acquired infections and is notorious for its ability to form drug-resistant biofilms. Despite the need for antibacterial agents that target S. aureusbiofilms, few chemical scaffolds are known that are capable of inhibiting, dispersing or eradicating their biofilms. Here, we report the discovery of bromophenazine derivatives that display antibiofilm activities as either potent biofilm inhibitors (IC sub(50) values 0.55-10.3 mu M) or dispersal agents (EC sub(50) values 1.4-29.3 mu M) and biofilm eradicators (MBEC values 100-200 mu M) against S. aureusstrains, including a methicillin-resistant Staphylococcus aureusclinical isolate. These discoveries could lead to the development of new treatment options that target drug-resistant, biofilm-associated S. aureusinfections.
ISSN:2046-2069
DOI:10.1039/c4ra08728c